Icon

FINTEPLA (nda212102)- (EQ 2.2MG BASE/ML)

FENFLURAMINE HYDROCHLORIDE UCB INC
EQ 2.2MG BASE/ML
Yes Yes
2039-Oct-22 Expired
None 2023-Jun-25
None No
FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.
0 0 0
Total Other Developers 2
Drugs with Suitability No
EQ 2.2MG BASE/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.